Diclofenac to prevent pancreatitis after ERCP
Treatments studied
Part of Digestive system clinical trials.
This trial tests whether taking diclofenac (an anti-inflammatory medicine) can lower the chance of getting pancreatitis after a procedure called ERCP. If you qualify, you may help researchers find a safer way to prevent this complication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled to have an ERCP procedure (a scope used to treat bile or pancreas problems)
- Your ERCP plan was decided before the procedure started (not changed during surgery)
- You do not have an allergy or intolerance to NSAID medicines like diclofenac
- You are not already taking NSAID medicines every day
- You are not pregnant, and you can understand the study in Swedish
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two common NSAID medications (indomethacin and diclofenac) given before an ERCP procedure to see if one is better at preventing pancreatitis, a common complication. If you are having an ERCP and meet the health criteria, you may be able to join.
This trial tests whether a single dose of tacrolimus, a medicine that calms the immune system, can lower the chance of developing pancreatitis (inflammation of the pancreas) after an ERCP procedure. ERCP is a procedure used to diagnose or treat problems in the bile ducts or pancreas.
This trial tests whether parecoxib or indomethacin works better at preventing pancreatitis, a common complication after a procedure called ERCP. Participants will receive one of the two medicines before the procedure, and the study will track which one is safer and more effective.
This Phase 3 study tests whether putting an anti-inflammatory medicine into the rectum (indomethacin) plus taking an immune-suppressing pill (tacrolimus) works better than using the two medicines in a different combination to prevent pancreatitis after an ERCP procedure. If you qualify, you may be assigned to one of the treatment options to lower your risk of post-ERCP pancreas inflammation.
This study tests whether combining a rectal anti-inflammatory medication (indomethacin) with cold water cooling of the pancreas opening during an endoscopic procedure can better prevent pancreatitis—a painful inflammation of the pancreas—compared to medication alone.
This trial tests if applying cold therapy or giving an NSAID (anti-inflammatory medication) before an ERCP can prevent pancreatitis, a common complication. It is for adults having their first ERCP.
Hear when a new Common Bile Duct Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.